| JXSS2100023 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-04-07 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-11-19 | view |
| JXSS2100021 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-04-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-11-19 | view |
| JXSL2100042 | Tiragolumab注射液 | tiragolumab | Injection | Biological Products(1) | Import Drug Application | 2021-03-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-03-24 | view |
| JXSL2100015 | RO7030816 | mosunetuzumab | Injection | Biological Products(1) | Import Drug Application | 2021-02-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-02-02 | view |
| JXSL2100016 | RO7030816 | mosunetuzumab | Injection | Biological Products(1) | Import Drug Application | 2021-02-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-02-02 | view |
| JXSL2100010 | Faricimab注射液 | faricimab | Injection | Biological Products(1) | Import Drug Application | 2021-01-25 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-01-25 | view |
| JXSL2100001 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-01-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-01-05 | view |
| JXSB2100002 | Tiragolumab注射液 | tiragolumab | Injection | Biological Products(1) | Supplementary Application | 2021-01-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-01-05 | view |
| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-03-17 | view |
| JXSS2000068 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-01-04 | view |
| JYSB2000692 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000694 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000691 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000689 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000690 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000695 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000688 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000693 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
| JYSB2000662 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | In Review | 2020-12-24 | view |
| JYHB2002697 | 马来酸咪达唑仑片 | midazolam maleate | Tablet | Chemical Drugs | Supplementary Application | 2020-12-28 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2021-02-24 | view |
